These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20127398)

  • 21. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
    Broshtilova V; Iliev E; Gantcheva M
    Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis.
    Tack CJ; Kleijwegt FS; Van Riel PL; Roep BO
    Diabetologia; 2009 Jul; 52(7):1442-4. PubMed ID: 19440690
    [No Abstract]   [Full Text] [Related]  

  • 23. [Etanercept for therapy of rheumatoid arthritis].
    Miyasaka N
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():521-5. PubMed ID: 15799411
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 25. Dermatological complications of etanercept therapy for rheumatoid arthritis.
    Misery L; Perrot JL; Gentil-Perret A; Pallot-Prades B; Cambazard F; Alexandre C
    Br J Dermatol; 2002 Feb; 146(2):334-5. PubMed ID: 11903255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Etanercept].
    Mühlhäuser U; Münzel F; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
    [No Abstract]   [Full Text] [Related]  

  • 27. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tuberculosis in two patients after administration of etanercept for rheumatoid arthritis].
    Shimzukawa M; Sakakibara T; Sato M; Okayama H; Miki M; Nakagawa K; Miura M; Ishii T; Sato Y
    Nihon Naika Gakkai Zasshi; 2007 Jul; 96(7):1476-8. PubMed ID: 17682437
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein].
    Fujikawa K; Kawakami A; Eguchi K
    Nihon Rinsho; 2007 Jul; 65(7):1211-7. PubMed ID: 17642234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis.
    Neregård P; Krishnamurthy A; Revu S; Engström M; af Klint E; Catrina AI
    Scand J Rheumatol; 2014; 43(2):85-90. PubMed ID: 24313444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
    Suzuki J; Goto H
    Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 33. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
    Ognenovski VM; Ojo TC; Fox DA
    J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
    [No Abstract]   [Full Text] [Related]  

  • 34. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract]   [Full Text] [Related]  

  • 35. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept-induced subacute cutaneous lupus erythematosus.
    Bleumink GS; ter Borg EJ; Ramselaar CG; Stricker BH
    Rheumatology (Oxford); 2001 Nov; 40(11):1317-9. PubMed ID: 11709621
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
    Mizutani W
    Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-TNF alpha therapy: a risk factor for legionella infection].
    Lagier JC; Andriamanantena D; Damiano J; Dot JM; Chaudier B; Margery J
    Rev Mal Respir; 2007 Nov; 24(9):1159-60. PubMed ID: 18176398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.